A study on the efficacy of the loss of response to jaw thrust as a clinical test to assess adequate depth of anesthesia using remimazolam besylate and the dose required for the loss of response.
- Conditions
- on-emergency patients undergoing surgery under general anesthesia
- Registration Number
- JPRN-jRCT1031210554
- Lead Sponsor
- Okuda Yasuhisa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
1) Patients with written consent to participate in this study.
2) Patients aged between 20 and 65 at the time of consent.
3) American Society of Anesthesiologists (ASA) Grade I or II patients.
4) Patients whose surgical purpose is other than heart surgery.
1) Patients undergoing emergency surgery.
2) Patients who may be pregnant.
3) Patients who are expected to have difficulty airway management or intubation.
4) BMI 28 and above.
5) Patients who have high risk of aspiration.
6) Patients with liver dysfunction: Child-pugh classification B or higher.
7) Patients with contraindications to propofol or remimazolam.
8) Patients with a history of alcoholism or drug abuse.
9) Patients who regularly use sedatives.
10) Patients with a history of cervical spine / cervical cord disease.
11) Patients with no eyelashes.
12) Patients with a history of cranial nerve system disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method